skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Peptides that stimulate subcutaneous adipogenesis

Patent ·
OSTI ID:1600346

Peptides of 5 to 14 amino acids in length that stimulate subcutaneous adipogenesis in mammals and uses thereof are provided.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC02-05CH11231; LB09005060
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
10,494,402
Application Number:
14/646,298
OSTI ID:
1600346
Resource Relation:
Patent File Date: 11/25/2013
Country of Publication:
United States
Language:
English

References (108)

Peptides that Stimulate Subcutaenouse Adipogenesis patent-application June 2014
Nucleic Acid and Corresponding Protein Entitled 121P1F1 Useful in Treatment and Detection of Cancer patent-application December 2003
Hyaluronan Accumulates With High-Fat Feeding and Contributes to Insulin Resistance journal January 2013
Adipose stromal/stem cells assist fat transplantation reducing necrosis and increasing graft performance journal July 2013
Modulation of Rhamm (CD168) for Selective Adipose Tissue Development patent-application June 2010
Method of Inhibiting Human Metapneumovirus and Human Coronavirus in Prevention and Treatment of Severe Acute Respiratory Syndrome (SARS) patent-application November 2004
Modulation of Rhamm (CD168) for selective adipose tissue development patent May 2014
Methods for the differentiation of human preadipocytes into adipocytes patent November 2000
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset journal April 2014
Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers patent January 2012
Preadipocyte Cell Strains and Uses Therefore patent-application January 2005
New Immunosuppressants: Testing and Development in Animal Models and the Clinic: with Special Reference to DSG journal December 1993
The Extracellular Signal-Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis journal January 2005
Hyaluronan receptor protein patent August 2002
Method and System for Preparing Soft Tissue for Grafting, Enhancing Grafting Results, and Grafting Autologous Fat and Adipocyte Derived Stem Cells to Soft Tissue Such as the Breast and Other Tissue Defects patent-application December 2009
Ace-inhibitory Peptides from Whey and Methods for Providing Same patent-application April 2010
Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes journal January 1993
Interactions of peptide mimics of hyaluronic acid with the receptor for hyaluronan mediated motility (RHAMM) journal October 2004
Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion journal June 2001
Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury: Enhancing wound healing with stem cells journal May 2006
Adipogenic differentiation of human mesenchymal stem cells patent March 2004
The mechanics of hyaluronic acid/adipic acid dihydrazide hydrogel: Towards developing a vessel for delivery of preadipocytes to native tissues journal December 2013
Anti-arthropod Vector Vaccines Method of Selecting and Uses Thereof patent-application September 2004
Tumor-associated Antigen RHAMM patent-application September 2003
Method and Device for Identifying Substances Capable of Modulating Adipocyte Differentiation patent-application February 2005
Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia journal July 1998
A RHAMM Mimetic Peptide Blocks Hyaluronan Signaling and Reduces Inflammation and Fibrogenesis in Excisional Skin Wounds journal October 2012
N-substituted Heterocycles for the Treatment of Hypercholesteremia, Dyslipidemia and other Metabolic Disorders; Cancer, and other Diseases patent-application July 2003
Purification of a hyaluronate-binding protein fraction that modifies cell social behavior journal October 1982
Peptides, compositions, and methods for stimulating subcutaneous adipogenesis patent-application August 2018
 -Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds journal April 2002
Bioinspired synthesis of self-assembled calcium phosphate nanocomposites using block copolymer-peptide conjugates journal December 2008
Signaling Properties of Hyaluronan Receptors journal February 2002
Compositions and Methods for Treating Cellular Response to Injury and Other Proliferating Cell Disorders Regulated by Hyaladherin and Hyaluronans patent-application May 2003
Method of Inducing Differentiation from Visceral Preadipocyte to Visceral Adipocyte patent-application July 2009
Methods and compositions for modulating adipocyte function patent August 2009
Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair journal December 2006
Human Hyaluronan Receptor patent-application January 2004
Hyperglycemia Diverts Dividing Osteoblastic Precursor Cells to an Adipogenic Pathway and Induces Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes journal April 2014
The Role of Ghrelin and Growth Hormone Secretagogues Receptor on Rat Adipogenesis journal March 2003
Compositions Affecting Hyaluronic Acid Mediated Activity patent-application November 2010
Methods of identifying adipocyte specific genes, the genes identified, and their uses patent-application November 2011
Inhibitors of formation of protease resistant prion protein patent April 2001
RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability journal June 2003
RHAMM Promotes Interphase Microtubule Instability and Mitotic Spindle Integrity through MEK1/ERK1/2 Activity* journal August 2010
Self-assembling peptide amphiphiles and related methods for growth factor delivery patent June 2009
Antidiabetic Screening of Commercial Botanical Products in 3T3-L1 Adipocytes and db/db Mice journal June 2010
Cell Penetrating Peptides patent-application September 2008
Interferon-inducible Protein-10 (IP-10 or CXCL10) Chemokine Analogs for the Treatment of Human Diseases patent-application May 2007
The influence of the microenvironment on the malignant phenotype journal August 2000
TTLL4 Peptides and Vaccines Containing the Same patent-application August 2013
Adipocyte Differentiation-associated Gene and Protein patent-application July 2005
Assembly of Cell Culture Vessels patent-application December 2009
Enhanced affinity hyaluronan binding peptides patent August 2001
Hyaluronan: from extracellular glue to pericellular cue journal July 2004
Of Mice and Not Men: Differences between Mouse and Human Immunology journal February 2004
MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics patent-application September 2011
CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity journal September 1997
Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models journal July 2004
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase journal May 1998
Vaccinia Virus Polypeptides patent-application March 2012
RHAMM/CD168-R3 Peptide Vaccination of HLA-A2+ Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Multiple Myeloma (MM). journal November 2005
Compositions and Methods for Treating Cellular Response to Injury and Other Proliferating Cell Disorders Regulated by Hyaladherin and Hyalurons patent-application March 2005
Rhamm Peptide Conjugates patent-application February 2004
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. journal November 1993
Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. journal April 1993
Compositions and Methods for Analyzing Renal Cancer patent-application December 2007
Cosmetic Oral and/or Parenteral Use of Glucosamine Optionally in Combination with at Least One Polyphenol Compound, and Corresponding Composition patent-application December 2010
Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages journal August 2006
Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. journal April 1997
Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia journal August 2005
RHAMM Antagonist Antibodies patent-application September 2002
Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. journal March 1995
Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer journal February 2005
Hyaluronan-dependent pericellular matrix☆ journal November 2007
ANKRD26 and Its Interacting Partners TRIO, GPS2, HMMR and DIPA Regulate Adipogenesis in 3T3-L1 Cells journal May 2012
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? journal March 2008
Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors journal February 1999
Modulation of Rhamm-Caveolin/lipid Raft Interactions to Affect Development, Responses to Tissue Injury, Angiogenesis, Tumorigenesis, Metastasis and Growth Factor/cytokine Responses patent-application August 2007
A functional role for the p62–ERK1 axis in the control of energy homeostasis and adipogenesis journal February 2010
A Role for Hyaluronan in Macrophage Accumulation and Collagen Deposition after Bleomycin-Induced Lung Injury journal October 2000
Rhamm, a Co-receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations patent-application March 2010
Cell Culture Screen for Agents That Control Adipogenisis and Myofibroblast Differentiation patent-application October 2013
Anti-tnfα therapy is useful in rheumatoid arthritis and crohn’s disease: analysis of the mechanism of action predicts utility in other diseases journal December 1998
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility journal June 1992
MAP kinases and cell migration journal September 2004
The future of wound healing: Pursuing surgical models in transgenic and knockout mice journal October 2004
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans patent June 2005
RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy journal December 2004
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor) journal October 2003
Chimeric adenoviral coat protein and methods of using same patent October 2000
Adipose-derived stem cell-containing hyaluronic acid/alginate hydrogel improves vocal fold wound healing: AdMSC Hydrogel for Vocal Fold Wound Healing journal October 2013
The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments journal November 1999
PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair journal January 2004
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans patent March 2005
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. journal January 1994
Stretch-induced bladder smooth muscle cell (SMC) proliferation is mediated by RHAMM-dependent extracellular-regulated kinase (erk) signaling journal June 2001
Self-assembling Peptide Amphiphiles and Related Methods for Growth Factor Delivery patent-application September 2005
The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells journal June 1998
Hyaluronan and Homeostasis: A Balancing Act journal February 2002
Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation journal July 1995
Chronic liver injury, TGF-β, and cancer journal December 2001
Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis journal October 2003
Unconventional Secretory Routes: Direct Protein Export Across the Plasma Membrane of Mammalian Cells journal August 2005
Bloodstream Cells Phenotypically Identical to Human Mesenchymal Bone Marrow Stem Cells Circulate in Large Amounts Under the Influence of Acute Large Skin Damage: New Evidence for Their Use in Regenerative Medicine journal April 2006
Antiviral Agents for the Treatment, Control and Prevention of Infections by Coronavirus patent-application August 2007
Development of a Peptide Inhibitor of Hyaluronan-Mediated Leukocyte Trafficking journal September 2000
Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect patent-application March 2005